<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>We describe a very rare case of a patient who presented with red cell <z:mpath ids='MPATH_58'>aplasia</z:mpath> that later developed into myeloproliferation with <z:hpo ids='HP_0002863'>myelodysplasia</z:hpo> and eventually <z:hpo ids='HP_0001909'>leukemia</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain>A 63-year-old man presented with <z:hpo ids='HP_0001903'>anemia</z:hpo> and <z:hpo ids='HP_0001896'>reticulocytopenia</z:hpo> in May 1997 </plain></SENT>
<SENT sid="2" pm="."><plain>A bone marrow examination revealed erythroid <z:mpath ids='MPATH_58'>aplasia</z:mpath> with <z:mpath ids='MPATH_458'>normal</z:mpath> production of myeloid cells and megakaryocytes with a <z:mpath ids='MPATH_458'>normal</z:mpath> karyotype </plain></SENT>
<SENT sid="3" pm="."><plain>After the diagnosis of pure red cell <z:mpath ids='MPATH_58'>aplasia</z:mpath> was made, the patient was treated with <z:chebi fb="2" ids="8378">prednisolone</z:chebi> and then with <z:chebi fb="0" ids="4031">cyclosporin A</z:chebi> (CyA) </plain></SENT>
<SENT sid="4" pm="."><plain>Two weeks after the initiation of CyA treatment, the peripheral reticulocyte count began to increase with a regrowth of erythroid cells in the bone marrow </plain></SENT>
<SENT sid="5" pm="."><plain>Meanwhile, the peripheral white blood cell and platelet counts also increased to more than 10,000/microL and 1,000,000/microL, respectively </plain></SENT>
<SENT sid="6" pm="."><plain>Examination of a bone marrow aspirate in December 1997 revealed myelodysplastic changes with <z:mp ids='MP_0004027'>trisomy</z:mp> 8 </plain></SENT>
<SENT sid="7" pm="."><plain>Despite the discontinuation of CyA and the administration of <z:chebi fb="0" ids="28680">1-beta-D-arabinofuranosylcytosine</z:chebi> stearyl monophosphate, <z:hpo ids='HP_0001909'>leukemia</z:hpo> developed in August 1998 </plain></SENT>
<SENT sid="8" pm="."><plain>In September 1998, the patient died of <z:hpo ids='HP_0100806'>sepsis</z:hpo> during a neutropenic period that followed remission-induction therapy </plain></SENT>
<SENT sid="9" pm="."><plain>In the mechanism of pathogenesis, CyA may induce upon pure red cell <z:mpath ids='MPATH_58'>aplasia</z:mpath> a secondary <z:hpo ids='HP_0005547'>myeloproliferative disorder</z:hpo> with <z:hpo ids='HP_0002863'>myelodysplasia</z:hpo> and <z:hpo ids='HP_0001909'>leukemia</z:hpo> </plain></SENT>
<SENT sid="10" pm="."><plain>An alternative possibility is that CyA reduces autoimmune-mediated suppression of the underlying stem cell disorder and that the result of this reduction is the manifestation of myeloproliferation and <z:hpo ids='HP_0001909'>leukemia</z:hpo> </plain></SENT>
</text></document>